Free CME from PeerView


Nephrology CME

Shmuel Shoham, MD/Ghady Haidar, MD
Credits: 1.0 CME / AAPA
PVI, PeerView Institute for Medical Education
What’s New, and What’s Next? Customizing COVID-19 Prevention Approaches in Transplant Patients to Increase Uptake, Access, and Efficacy
Shmuel Shoham, MD / Ghady Haidar, MD
June 06, 2023
Credits: 1.5 CME / MOC / NCPD / AAPA
PVI, PeerView Institute for Medical Education
Fine-Tuning the Wave of Innovation in RCC: Personalized Management Across the Disease Spectrum
Sumanta Kumar Pal, MD, FASCO
June 03, 2023
Credits: 0.5 CME
Medical Learning Institute, Inc.
Visualizing Progress in the Treatment of Chronic Active Antibody-Mediated Rejection: A Closer Look at the Clinical Potential of Targeting IL-6 to Improve Outcomes in the Kidney Transplant Setting
Stanley C. Jordan, MD, FASN, FAST
May 11, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Improving the Patient Experience in SLE and LN: The Intersection of Early Diagnosis, Individualized Treatment, and Culturally Competent Care
Saira Z. Sheikh, MD, FAAAAI, FACAAI, FACR / Brad Rovin, MD, FASN, FACP
March 29, 2023
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Breaking New Ground in RCC Management: Expert Guidance on Leveraging Therapeutic Strategies
Sumanta Kumar Pal, MD, FASCO
February 17, 2023
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Targeted Complements: Exploring New Horizons Designed to Address Gaps in Treating Complement-Associated Kidney Diseases
Gerald Appel, MD, PhD
December 29, 2022
Credits: 1.25 CPE
Purdue University College of Pharmacy
Novel Strategies for Managing Patients With CKD-Associated Anemia: What Do Health-System Pharmacists Need to Know About HIF-PH Inhibitors?
Jay B. Wish, MD
December 21, 2022
Credits: 1.25 CME
Medical Learning Institute, Inc.
Demystifying Cold Agglutinin Disease: A Visual Exploration of Mechanism, Diagnosis, and the Role of Complement Inhibition in Addressing Unmet Needs
Sigbjørn Berentsen, MD, PhD / Ilene C. Weitz, MD
December 09, 2022
Credits: 1.5 CME / MOC
PSU, Penn State University
The Future is Now in MDS: Integrating Innovative, Risk-Adapted Therapies Into Patient Management
Guillermo Garcia-Manero, MD
December 09, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
How I Think, How I Treat—Assessing, Managing, and Engaging Patients to Optimize Care in SLE and LN: Comparing Approaches With the Experts
Maureen A. McMahon, MD
November 15, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
RCC Clinical Consults: Making Difficult Treatment Decisions at the Intersection of the Data and the Real World
Sumanta Kumar Pal, MD, FASCO
November 04, 2022
Johns Hopkins University School of Medicine
Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your Knowledge
Shmuel Shoham, MD
July 08, 2022
PVI, PeerView Institute for Medical Education
Refining RCC Management Across the Disease Continuum: An Expert Clinical Consult on Leveraging New Evidence and Novel Therapeutic Strategies to Personalize Patient Care
Toni K. Choueiri, MD
June 04, 2022
Medical Learning Institute, Inc.
A Renewed Look at MRA Therapy: Improving Renal Outcomes and Reducing Risks in Patients With Type 2 Diabetes
Rajiv Agarwal, MD, MS
May 13, 2022
Penn State College of Medicine
Mapping the Therapeutic Odyssey in Multiple Myeloma: Interprofessional Guidance on Evidence-Based Treatment Selection and Sequencing
Nina Shah, MD
May 09, 2022
Medical Learning Institute, Inc.
Making Sense of the Evolving Treatment Landscape in Ovarian Cancer Care: Pharmacy Perspectives on PARP Inhibitor Therapy
Thomasina Morris, RPh, MHA, BCOP
May 06, 2022
Medical Learning Institute, Inc.
Making Sense of New Standards for CLL: Pharmacist Insights on Targeted Therapy and the Delivery of Team-Based Care
Amber C. King, PharmD, BCOP
May 06, 2022
PVI, PeerView Institute for Medical Education
Aligning Nursing Care Strategies With Evolving Patient Needs in RCC: Interprofessional Insights on Optimizing Outcomes With Novel Targeted and Immune-Based Therapies
Nancy P. Moldawer, RN, MSN
May 01, 2022
Medical Learning Institute, Inc.
How to Harness Adjuvant CDK4 and 6 Inhibition to Prevent Recurrences in High-Risk HR+/HER2- Early Breast Cancer: New Goals and Better Tools to Close the Gaps
Erika Hamilton, MD
April 29, 2022
Medical Learning Institute, Inc.
Expanding the Benefits and Refining the Role of Immune Checkpoint Inhibitors in the Treatment of Recurrent and Advanced Endometrial Cancer
Bhavana Pothuri, MD, MS
April 27, 2022
PVI, PeerView Institute for Medical Education
Weighing the Evidence, Parsing the Practicalities: Integrating New Treatment Options Into the SCLC Treatment Arsenal to Improve Patient Outcomes in Oncology Practice
Jacob Sands, MD
April 27, 2022
PVI, PeerView Institute for Medical Education
Cancer Control Through Early Blood-Based Detection: Perspectives on Integrating Innovative Multicancer Early Detection Tests in the Primary Care Setting
John J. Russell, MD
April 22, 2022
PVI, PeerView Institute for Medical Education
Sharing the Cure: Best Practices for Primary Care Providers to Improve HCV Prevention, Care, and Treatment
Anthony Martinez, MD, AAHIVS, FAASLD
April 21, 2022
PVI, PeerView Institute for Medical Education
New Evidence on Cardiac Myosin Inhibition in Hypertrophic Cardiomyopathy: Analysis From Washington, DC
Milind Desai, MD, MBA
April 20, 2022
Medical Learning Institute, Inc.
Making the Case for Preventing and Managing Nephropathy in Patients With Fabry Disease
Anjay Rastogi, MD
April 19, 2022
Medical Learning Institute, Inc.
Expanding the Benefits of PARP Inhibitors to More Patients With Breast Cancer and Earlier Settings
Henry M. Kuerer, MD, PhD, FACS
April 08, 2022
PVI, PeerView Institute for Medical Education
Dialing in the Dose: Reviewing Recent Evidence and Team-Based Strategies to Personalize and Optimize Patient Care in Metastatic Colorectal Cancer
Tanios Bekaii-Saab, MD
April 07, 2022
Medical Learning Institute, Inc.
Solving the Challenge of Tumor Lysis Syndrome: Expert Insight and Guidance on a Challenging Oncologic Emergency
Anthony R. Mato, MD, MSCE
April 04, 2022
Medical Learning Institute, Inc.
When Are PARP Inhibitors the Best Choice for Patients With Ovarian Cancer? Personalizing Therapeutic Selection Across the Disease Continuum
Bradley J. Monk, MD, FACS, FACOG
March 22, 2022
PVI, PeerView Institute for Medical Education
Translating Progress With Immunotherapies and Targeted Agents Into Improved Outcomes in Triple-Negative Breast Cancer: Surgical and Clinical Perspectives on Modern Multimodal Treatment Approaches
Henry M. Kuerer, MD, PhD, FACs / Heather L. McArthur, MD, MPH
March 12, 2022

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView